Expression of 11?-hydroxysteroid dehydrogenase in rat osteoblastic cells: Pre-receptor regulation of glucocorticoid responses in bone
- 8 March 2001
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 81 (3) , 453-462
- https://doi.org/10.1002/1097-4644(20010601)81:3<453::aid-jcb1059>3.0.co;2-z
Abstract
11β‐hydroxysteroid dehydrogenase (11β‐HSD) acts as a pre‐receptor signaling mechanism for corticosteroids by regulating the access of active glucocorticoids to both glucocorticoid (GR) and mineralocorticoid receptors (MR). To examine the relationship between endogenous glucocorticoid metabolism and osteoblast function, we have characterized the expression of 11β‐HSD isozymes in rat osteosarcoma cells. Analysis of mRNA from ROS 25/1, UMR 106 and ROS 17/2.8 cells revealed transcripts for both 11β‐HSD type 1 (11β‐HSD1) and type 2 (11β‐HSD2) in all three cell lines. However, enzyme activity studies showed only high affinity dehydrogenase activity (inactivation of corticosterone (B) to 11‐dehydrocorticosterone (A)), characteristic of 11β‐HSD2; conversion of B to A was higher in ROS 25/1> UMR 106 cells>ROS 17/2.8. Although all three cell lines had similar numbers of GR (50,000/cell), glucocorticoid modulation of alkaline phosphatase activity and cell proliferation was only detectable in ROS 17/2.8 cells. Further studies showed that 11β‐HSD2 activity in each of the cells was potently stimulated by both A and B, but not by synthetic dexamethasone. This effect was blocked by the 11β‐HSD inhibitor, 18β‐glycyrrhetinic acid (but not by GR or MR antagonists) suggesting direct, allosteric regulation of 11β‐HSD2 activity. These data indicate that in osteosarcoma cells 11β‐HSD2 plays a key role in controlling GR‐mediated responses; cells with relatively high levels of 11β‐HSD2 activity were insensitive to glucocorticoids, whilst cells with low levels showed functional responses to both dexamethasone and B. In addition to the established effects of 11β‐HSD2 in protecting MR in the kidney and colon, our data suggest that 11β‐HSD2 in bone represents an important pre‐receptor mechanism in determining ligand availability to GR. J. Cell. Biochem. 81:453–462, 2001.Keywords
This publication has 42 references indexed in Scilit:
- Characterization of Aromatase and 17β-Hydroxysteroid Dehydrogenase Expression in Rat Osteoblastic CellsJournal of Bone and Mineral Research, 1998
- Oestrogen formation from androstenedione in human boneClinical Endocrinology, 1995
- Aromatase in bone cell: Association with osteoporosis in postmenopausal womenThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- Cortisol downregulates osteoblast α1(I) procollagen mRNA by transcriptional and posttranscriptional mechanismsJournal of Cellular Biochemistry, 1995
- Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzymeMolecular and Cellular Endocrinology, 1994
- Mechanisms of glucocorticoid action in bone cellsJournal of Cellular Biochemistry, 1994
- Glucocorticoids stimulate resorption in fetal rat parietal bones in vitroJournal of Bone and Mineral Research, 1990
- Evidence for kinetically distinct forms of corticosteroid 11β-dehydrogenase in rat liver microsomesThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoidsMetabolic Bone Disease and Related Research, 1984
- CorticosteroidsDrugs, 1978